Proyecto
 (2016)

Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/​Esophagus Junction Cancer (CheckMate649)

Bristol-Myers Squibb; Janjigian, YY; Skoczylas T, et al.

Más información

Fecha de publicación: 2016
Objetivos: The main purpose of this study is to compare how long patients with gastric or gastroesophageal junction cancer live after receiving nivolumab and ipilimumab or nivolumab and chemotherapy compared with patients receiving chemotherapy alone.
Año de Inicio/Término: 2016-2024
Financiamiento/Sponsor: Bristol-Myers Squibb
Rol del Usuario: COINVESTIGADOR(A)
URL: https://clinicaltrials.gov/study/NCT02872116#study-overview
DOI:

NCT02872116